Şunu aradınız:: rimonabant (İngilizce - Slovence)

levels of rimonabant.
sočasna uporaba orlistata, etanola ali lorazepama ni pomembno vplivala na koncentracijo rimonabanta v plazmi.

the active substance is rimonabant.
zdravilna učinkovina je rimonabant.

no adverse effect of rimonabant du
med 3- mesečno študijo na psih

each tablet contains 20 mg rimonabant.
ena tableta vsebuje 20 mg rimonabanta.

each tablet contains 20 mg of rimonabant.
ena tableta vsebuje 20 mg rimonabanta.

the active ingredient of acomplia is rimonabant.
zdravilna učinkovina v zdravilu acomplia je rimonabant.

zimulti 20 mg film-coated tablets rimonabant
zimulti 20 mg filmsko obložene tablete rimonabant

d ise each tablet contains 20 mg of rimonabant.
t me ena tableta vsebuje 20 mg rimonabanta.

or acomplia 20 mg film-coated tablets rimonabant
acomplia 20 mg filmsko obložene tablete rimonabant

rimonabant 20 mg reduced the risk of weight regain.
rimonabant v odmerku 20 mg je zmanjšal tveganje za ponovno povečanje telesne mase.

a direct effect of rimonabant cannot be ruled out.
neposrednega učinka rimonabanta ni mogoče izključiti.

acomplia is a medicine containing the active substance rimonabant.
acomplia je zdravilo, ki vsebuje zdravilno učinkovino rimonabant.

potential for other medicinal products to affect rimonabant: d
induktorjev cyp3a4 zmanjša izpostavljenost rimonabantu. nim

rimonabant pharmacokinetics are fairly dose proportional up to about 20 mg.
farmakokinetika rimonabanta je do približno 20 mg precej sorazmerna odmerku.

rimonabant has not been studied in patients being treated for epilepsy.
pri bolnikih, ki so se zdravili zaradi epilepsije, uporabe rimonabanta niso proučevali.

however, in vitro, rimonabant had a mild inhibitory effect on cyp2c8.
vendar rimonabant in vitro rahlo zavira cyp2c8.

the active substance in acomplia, rimonabant, is a cannabinoid receptor antagonist.
zdravilna učinkovina v zdravilu acomplia, rimonabant, je antagonist kanabinoidnih receptorjev.

• seizures rimonabant has not been studied in patients being treated for epilepsy.
• epileptični napadi rav

if psychiatric illness is diagnosed during rimonabant therapy, treatment must be stopped. ro
Če se med zdravljenjem z rimonabantom ugotovi resna duševna motnja, je treba zdravljenje z rimonabantom prekiniti. ilo

rimonabant should be used with caution in this population (see section 5.2).
rimonabant morate v tej populaciji uporabljati previdno (glejte poglavje 5.2).